Ian D. Dang

Array ( [id] => 5726917 [patent_doc_number] => 20060057677 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Organic anion transporter and gene coding for the same' [patent_app_type] => utility [patent_app_number] => 11/259417 [patent_app_country] => US [patent_app_date] => 2005-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4591 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20060057677.pdf [firstpage_image] =>[orig_patent_app_number] => 11259417 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5742776 [patent_doc_number] => 20060088501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'Duffy antigen receptor for chemokines and use thereof' [patent_app_type] => utility [patent_app_number] => 11/254222 [patent_app_country] => US [patent_app_date] => 2005-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6298 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20060088501.pdf [firstpage_image] =>[orig_patent_app_number] => 11254222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5264913 [patent_doc_number] => 20090117598 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => 'Method for identifying compounds that affect a transport of a protein through a membrane trafficking pathway' [patent_app_type] => utility [patent_app_number] => 11/665184 [patent_app_country] => US [patent_app_date] => 2005-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 3896 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20090117598.pdf [firstpage_image] =>[orig_patent_app_number] => 11665184 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5720404 [patent_doc_number] => 20060073178 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-06 [patent_title] => 'Method and composition for restoration of age related tissue loss in the face or selected areas of the body' [patent_app_type] => utility [patent_app_number] => 11/241005 [patent_app_country] => US [patent_app_date] => 2005-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5153 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20060073178.pdf [firstpage_image] =>[orig_patent_app_number] => 11241005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5720788 [patent_doc_number] => 20060073563 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-06 [patent_title] => 'Erythropoietin derivatives with altered immunogenicity' [patent_app_type] => utility [patent_app_number] => 11/218928 [patent_app_country] => US [patent_app_date] => 2005-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 17097 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20060073563.pdf [firstpage_image] =>[orig_patent_app_number] => 11218928 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 177918 [patent_doc_number] => 07655626 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-02 [patent_title] => 'Antiangiogenic peptides' [patent_app_type] => utility [patent_app_number] => 11/573660 [patent_app_country] => US [patent_app_date] => 2005-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 19348 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 179 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/655/07655626.pdf [firstpage_image] =>[orig_patent_app_number] => 11573660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4693089 [patent_doc_number] => 20080085860 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-10 [patent_title] => 'Selective Vpac2 Receptor Peptide Agonists' [patent_app_type] => utility [patent_app_number] => 11/573896 [patent_app_country] => US [patent_app_date] => 2005-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28322 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20080085860.pdf [firstpage_image] =>[orig_patent_app_number] => 11573896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6930744 [patent_doc_number] => 20050281778 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Human growth hormone conjugated with biocompatible polymer' [patent_app_type] => utility [patent_app_number] => 11/187522 [patent_app_country] => US [patent_app_date] => 2005-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 13343 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20050281778.pdf [firstpage_image] =>[orig_patent_app_number] => 11187522 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8305883 [patent_doc_number] => 08227418 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-24 [patent_title] => 'Alpha-defensins as anthrax immunotherapeutics' [patent_app_type] => utility [patent_app_number] => 11/632956 [patent_app_country] => US [patent_app_date] => 2005-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7602 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11632956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5721245 [patent_doc_number] => 20060074020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-06 [patent_title] => 'Inhibition of angiogenesis by neutrophil alpha-defensins' [patent_app_type] => utility [patent_app_number] => 11/185626 [patent_app_country] => US [patent_app_date] => 2005-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16138 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20060074020.pdf [firstpage_image] =>[orig_patent_app_number] => 11185626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5391658 [patent_doc_number] => 20090208971 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'Insulin promoter factor 1 as target/marker of beta cell failure' [patent_app_type] => utility [patent_app_number] => 11/658458 [patent_app_country] => US [patent_app_date] => 2005-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7887 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20090208971.pdf [firstpage_image] =>[orig_patent_app_number] => 11658458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5913557 [patent_doc_number] => 20060128619 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-15 [patent_title] => 'Therapeutic use of modulators of notch' [patent_app_type] => utility [patent_app_number] => 11/178724 [patent_app_country] => US [patent_app_date] => 2005-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 37318 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20060128619.pdf [firstpage_image] =>[orig_patent_app_number] => 11178724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5693747 [patent_doc_number] => 20060153894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Multi-compartment delivery system' [patent_app_type] => utility [patent_app_number] => 11/170410 [patent_app_country] => US [patent_app_date] => 2005-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6510 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20060153894.pdf [firstpage_image] =>[orig_patent_app_number] => 11170410 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5738458 [patent_doc_number] => 20060008849 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Methods for measuring chloride channel conductivity' [patent_app_type] => utility [patent_app_number] => 11/158001 [patent_app_country] => US [patent_app_date] => 2005-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7595 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20060008849.pdf [firstpage_image] =>[orig_patent_app_number] => 11158001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 586892 [patent_doc_number] => 07435410 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-14 [patent_title] => 'Methods of treatment with interferson and albumin fusion protein' [patent_app_type] => utility [patent_app_number] => 11/146077 [patent_app_country] => US [patent_app_date] => 2005-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 38 [patent_no_of_words] => 12641 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/435/07435410.pdf [firstpage_image] =>[orig_patent_app_number] => 11146077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4698839 [patent_doc_number] => 20080221023 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'Use of Protein Hydrolysates For the Manufacture of a Medicament For Prophylaxis and/or Treatment of a Dpp-IV Mediated Condition' [patent_app_type] => utility [patent_app_number] => 11/597722 [patent_app_country] => US [patent_app_date] => 2005-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3855 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20080221023.pdf [firstpage_image] =>[orig_patent_app_number] => 11597722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5514125 [patent_doc_number] => 20090214431 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'IDENTIFICATION OF ERGOTHIONEINE TRANSPORTER AND THERAPEUTIC USES THEREOF' [patent_app_type] => utility [patent_app_number] => 11/569451 [patent_app_country] => US [patent_app_date] => 2005-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 24515 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 39 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20090214431.pdf [firstpage_image] =>[orig_patent_app_number] => 11569451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5835332 [patent_doc_number] => 20060247163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Methods and compositions for control of fetal growth via modulation of relaxin' [patent_app_type] => utility [patent_app_number] => 11/120582 [patent_app_country] => US [patent_app_date] => 2005-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 32393 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20060247163.pdf [firstpage_image] =>[orig_patent_app_number] => 11120582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5769408 [patent_doc_number] => 20050265968 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Method of treating IL-10 deficiency' [patent_app_type] => utility [patent_app_number] => 11/112369 [patent_app_country] => US [patent_app_date] => 2005-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7470 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20050265968.pdf [firstpage_image] =>[orig_patent_app_number] => 11112369 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5187970 [patent_doc_number] => 20070166278 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-19 [patent_title] => 'Novel g-csf conjugates' [patent_app_type] => utility [patent_app_number] => 11/578390 [patent_app_country] => US [patent_app_date] => 2005-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 7783 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20070166278.pdf [firstpage_image] =>[orig_patent_app_number] => 11578390 [rel_patent_id] =>[rel_patent_doc_number] =>)